The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The efficacy and safety profile of anlotinib with etoposide plus cisplatin/carboplatin in treatment-naive extensive-stage small cell lung cancer(SCLC) patients: Results from a phase II single-arm trial.
 
Pengbo Deng
No Relationships to Disclose
 
Huaping Yang
No Relationships to Disclose
 
Cen Chen
No Relationships to Disclose
 
Chengping Hu
No Relationships to Disclose
 
Liming Cao
No Relationships to Disclose
 
Qihua Gu
No Relationships to Disclose
 
Jian An
No Relationships to Disclose
 
Bin Li
No Relationships to Disclose
 
Yongjun Tang
No Relationships to Disclose
 
Jie Meng
No Relationships to Disclose
 
Juntao Feng
No Relationships to Disclose